These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28363732)

  • 1. Race, Serum Potassium, and Associations With ESRD and Mortality.
    Chen Y; Sang Y; Ballew SH; Tin A; Chang AR; Matsushita K; Coresh J; Kalantar-Zadeh K; Molnar MZ; Grams ME
    Am J Kidney Dis; 2017 Aug; 70(2):244-251. PubMed ID: 28363732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.
    Eriguchi R; Obi Y; Soohoo M; Rhee CM; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2019; 50(5):361-369. PubMed ID: 31522173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort.
    Kim T; Rhee CM; Streja E; Soohoo M; Obi Y; Chou JA; Tortorici AR; Ravel VA; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2017; 45(6):509-521. PubMed ID: 28528336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
    Nakhoul GN; Huang H; Arrigain S; Jolly SE; Schold JD; Nally JV; Navaneethan SD
    Am J Nephrol; 2015; 41(6):456-63. PubMed ID: 26228532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.
    Chatterjee R; Yeh HC; Shafi T; Anderson C; Pankow JS; Miller ER; Levine D; Selvin E; Brancati FL
    Am J Clin Nutr; 2011 May; 93(5):1087-91. PubMed ID: 21367942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).
    Babayev R; Whaley-Connell A; Kshirsagar A; Klemmer P; Navaneethan S; Chen SC; Li S; McCullough PA; Bakris G; Bomback A;
    Am J Kidney Dis; 2013 Mar; 61(3):404-12. PubMed ID: 23260275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
    Newsome BB; McClellan WM; Allison JJ; Eggers PW; Chen SC; Collins AJ; Kiefe CI; Coffey CS; Warnock DG
    Am J Kidney Dis; 2008 Aug; 52(2):251-61. PubMed ID: 18468746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
    Scialla JJ; Parekh RS; Eustace JA; Astor BC; Plantinga L; Jaar BG; Shafi T; Coresh J; Powe NR; Melamed ML
    Am J Nephrol; 2015; 42(1):25-34. PubMed ID: 26287973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
    Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
    Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine, race, and mortality in hemodialysis patients.
    Drew DA; Tighiouart H; Scott T; Kantor A; Fan L; Artusi C; Plebani M; Weiner DE; Sarnak MJ
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1426-33. PubMed ID: 24970872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.
    Chen Y; Chang AR; McAdams DeMarco MA; Inker LA; Matsushita K; Ballew SH; Coresh J; Grams ME
    Mayo Clin Proc; 2016 Oct; 91(10):1403-1412. PubMed ID: 27499535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.
    Bash LD; Astor BC; Coresh J
    Am J Kidney Dis; 2010 Jan; 55(1):31-41. PubMed ID: 19932544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans.
    Matsushita K; Sang Y; Yang C; Ballew SH; Grams ME; Coresh J; Molnar MZ
    PLoS One; 2019; 14(8):e0219899. PubMed ID: 31393910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences.
    Bleyer AJ; Tell GS; Evans GW; Ettinger WH; Burkart JM
    Am J Kidney Dis; 1996 Jul; 28(1):72-81. PubMed ID: 8712225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in inflammation and outcomes of aging among kidney transplant candidates.
    Shrestha P; Haugen CE; Chu NM; Shaffer A; Garonzik-Wang J; Norman SP; Walston JD; Segev DL; McAdams-DeMarco MA
    BMC Nephrol; 2019 May; 20(1):176. PubMed ID: 31101015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients.
    Park J; Jin DC; Molnar MZ; Dukkipati R; Kim YL; Jing J; Levin NW; Nissenson AR; Lee JS; Kalantar-Zadeh K
    Mayo Clin Proc; 2013 May; 88(5):479-86. PubMed ID: 23562348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age, Race and Cardiovascular Outcomes in African American Veterans.
    Norris KC; Mensah GA; Boulware LE; Lu JL; Ma JZ; Streja E; Molnar MZ; Kalantar-Zadeh K; Kovesdy CP
    Ethn Dis; 2016 Jul; 26(3):305-14. PubMed ID: 27440969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
    Gutiérrez OM; Parsa A; Isakova T; Scialla JJ; Chen J; Flack JM; Nessel LC; Gupta J; Bellovich KA; Steigerwalt S; Sondheimer JH; Wright JT; Feldman HI; Kusek JW; Lash JP; Wolf M
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):653-62. PubMed ID: 26912553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
    Bhavsar NA; Appel LJ; Kusek JW; Contreras G; Bakris G; Coresh J; Astor BC;
    Am J Kidney Dis; 2011 Dec; 58(6):886-93. PubMed ID: 21944667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study.
    Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Kimura H; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin Exp Nephrol; 2021 Apr; 25(4):410-417. PubMed ID: 33411113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.